Profile
Our lab's current research focuses on understanding virus biology and pathogenesis and actively engaging in next-generation vaccine development and anti-viral drugs. Our lab's long-standing research interest is to carry out innovative scientific research on arboviruses, respiratory viruses, and emerging viruses (Nipah, CCHFV) by leveraging on the expertise gained from HIV, influenza, and paramyxoviruses, thus creating a'Translational Virology Platform. We have developed an indigenous novel multivalent self-assembled nanocage based vaccine platform and collaborating with industry for the rapid development of affordable and indigenous subunit protein based vaccines. Additionally, we are developing preclinical animal models and assays to facilitate the development of vaccines, biotherapeutics, and anti-viral drugs. We are seeking collaboration with industrial, academic, and start-ups to jointly develop affordable vaccines and drugs for patients-in need.
Current Focus Areas
Fundamental and translational virology targeting human viruses